Clinical Trial Update: Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer [EARLY_Phase 1]

View source ↗

Summary

This early-phase study evaluates trametinib in combination with paclitaxel for anaplastic thyroid cancer and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Trametinib (trametinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Anaplastic Thyroid Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING